Blockchain Registration Transaction Record

Cure Alzheimer’s Fund Strengthens Board with Two New Appointments

Cure Alzheimer’s Fund appoints Christine Villas-Boas & Brittany Bowlen to its Board, enhancing its mission to fund research for a cure against Alzheimer’s disease.

The appointment of Christine Villas-Boas and Brittany Bowlen to the Cure Alzheimer’s Fund Board of Directors signifies a bolstering of leadership and expertise in the fight against Alzheimer’s disease. With Alzheimer’s affecting an increasing number of individuals and families globally, the fund's dedication to funding critical research is more important than ever. The new board members' diverse backgrounds and commitment to philanthropy will enhance the organization's efforts to find a cure, offering hope to millions affected by this devastating disease. Their leadership is a testament to the fund's commitment to transparency and efficiency, ensuring that every dollar donated goes directly towards research that could one day prevent, slow, or reverse Alzheimer’s.